He answered the question whether a nasal vaccine is being created as an add-on to the Sputnik V vaccine.
According to him, one of the tasks is to immunize people in this way.
“Then the immunization of those who were immunized and those who had recovered from it.
And, in fact, within the framework of such clinical trials, within the framework of such a protocol, we will understand how effective such an approach is in protecting different cohorts of people, ”said Logunov.
He also expressed the hope that "just intranasal immunization will be sufficient."
Logunov also admitted that studies of the intranasal vaccine will be carried out in 2022.
“Timing always depends on the recruitment of volunteers.
That is, to produce a vaccine, to have a drug for research - it will not just be produced, it will be produced in the near future.
Therefore, the study can start there, relatively speaking, in January 2022.
And this whole study, that is, the first and second phases, which are classic, can take several months, ”he said.
Earlier, Russian President Vladimir Putin expressed his readiness to take part in the test of the nasal form of the vaccine against COVID-19.
In May, the director of the Gamaleya Center, Alexander Gintsburg, said that registration of a nasal vaccine against coronavirus infection could occur in 2022.